ABVX

Abivax (ABVX)

Abivax SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ABVX

Date	Time	Source	Headline	Symbol	Company
01/23/2025	4:05PM	GlobeNewswire Inc.	Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress	NASDAQ:ABVX	Abivax SA
01/10/2025	9:04AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
01/09/2025	11:35AM	GlobeNewswire Inc.	Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment	NASDAQ:ABVX	Abivax SA
12/23/2024	5:14PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
12/23/2024	4:05PM	GlobeNewswire Inc.	Abivax Announces a Change to the Composition of its Board of Directors	NASDAQ:ABVX	Abivax SA
11/27/2024	12:15AM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ABVX	Abivax SA
11/19/2024	4:43PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
11/19/2024	4:30PM	GlobeNewswire Inc.	Abivax Establishes an At-the-Market (ATM) Program on Nasdaq	NASDAQ:ABVX	Abivax SA
11/19/2024	4:02PM	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:ABVX	Abivax SA
11/14/2024	4:01PM	GlobeNewswire Inc.	Abivax presents third quarter 2024 key financial information	NASDAQ:ABVX	Abivax SA
11/14/2024	4:00PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
11/13/2024	4:01PM	GlobeNewswire Inc.	Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax	NASDAQ:ABVX	Abivax SA
10/07/2024	4:01PM	GlobeNewswire Inc.	Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation	NASDAQ:ABVX	Abivax SA
10/03/2024	4:18PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
10/03/2024	4:01PM	GlobeNewswire Inc.	Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease	NASDAQ:ABVX	Abivax SA
10/03/2024	6:05AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
10/03/2024	2:31AM	GlobeNewswire Inc.	Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance	NASDAQ:ABVX	Abivax SA
09/26/2024	6:05AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
09/26/2024	2:30AM	GlobeNewswire Inc.	Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024	NASDAQ:ABVX	Abivax SA
09/25/2024	4:30PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
09/25/2024	4:01PM	GlobeNewswire Inc.	Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model	NASDAQ:ABVX	Abivax SA
09/09/2024	4:27PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
09/09/2024	4:05PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
09/09/2024	4:01PM	GlobeNewswire Inc.	Abivax presents first-half 2024 financial results	NASDAQ:ABVX	Abivax SA
09/09/2024	6:09AM	IH Market News	U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns	NASDAQ:ABVX	Abivax SA
08/06/2024	2:30AM	GlobeNewswire Inc.	Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone	NASDAQ:ABVX	Abivax SA
07/15/2024	4:00PM	GlobeNewswire Inc.	Abivax Provides Operational and Key Program Update	NASDAQ:ABVX	Abivax SA
06/04/2024	4:26PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
06/04/2024	4:10PM	GlobeNewswire Inc.	Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting	NASDAQ:ABVX	Abivax SA
05/07/2024	4:26PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA